BFRI
Biofrontera Inc.
$0.95
-0.07 (-7.25%)
Institutional flow:
-14% holders QoQ · +2 funds added
Volume signal:
High volume on a down day — possible exhaustion
1 Down Day
Indicators
Price
Panels
Event markers
Price & Indicators
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.95
Open$1.01
Day$0.92–1.03
52W$0.56–1.19
Avg vol 30d204K
Short int56K · 1.0d
Short vol36%
Last earningsMay 14, 2026
DataOct 2021–Jun 2026
Filing10-Q · May 14
Equibles Rating
blended score
Overall
Buy
Technical · trend & momentum
Buy
+
Price vs 200-day avg · +3% above
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+3% above
◦
Price vs 50-day avg
−3% below
◦
RSI (14)
49 · neutral
+
MACD trend
positive
◦
52-week position
62% · mid-range
Sentiment · smart money
Neutral
+
Short interest · 0.44% of float · ▼ -19.2% MoM · 1.0 days cover
◦
Trend (MA cross)
50d $1 › 200d $1 — 50d above 200d
−
Institutional flow
-14% holders QoQ · +2 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.44% of float · ▼ -19.2% MoM · 1.0 days cover
◦
Volume signal
High volume on a down day — possible exhaustion
◦
Institution breadth
12 holders — mid 3-yr range
Fundamentals
Strong
+
Revenue growth · +19% Y/Y
+
Revenue growth
+19% Y/Y
+
EPS growth
+68% Y/Y
−
Free cash flow
$-13.4M
+
Balance sheet
net cash $6.4M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Key facts
Market Cap
$12.11M
Shares
12,803,344
CIK
1858685
CUSIP
09077D209
Website
Visit website
Investor Relations
Investor relations
Up next
Next earnings call
Aug 13, 2026
Est · unconfirmed
· in 6 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+3% above
Bullish
Price vs 50-day avg
−3% below
Neutral
RSI (14)
49 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
62% · mid-range
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow
Distributing
-14% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.44% of float · ▼ -19.2% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
12 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1
Now $1 · 62%
52-wk high $1
vs 200-day avg +3%
vs 50-day avg -3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | -$3.6M | Q1 2026 | — |
| Adjusted EBITDA margin non-GAAP | -35.3% | first quarter of 2026 | — |
| Ameluz units sold growth | 16% | first quarter of 2026 | — |
| Cash used in operations | $70K | Q1 2026 | — |
| Operating cash balance | $6.3M | as of March 31, 2026 | — |
Figures exactly as the company stated them · period links open the stating release · YoY needs the prior-year figure on file
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BFRI
this stock
Biofrontera Inc.
|
$12.11M | +66.0% | +19.0% | — | 0.4% |
|
GALDY
Galderma Group AG/ADR
|
$53.33B | +9.7% | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$50.65B | +2.8% | — | — | 0.3% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$41.35B | -7.7% | — | — | 0.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BFRI | -8.2% | -0.9% | +19.0% | +6.8% | +66.0% |
| SPY | +1.8% | -1.6% | +7.9% | -1.3% | +9.5% |
| vs SPY | -10.0% | +0.7% | +11.1% | +8.1% | +56.5% |